Goedegebuure Peter S相关文献与解析，生知库

Mammaglobin-A cDNA vaccination of breast cancer patients induces antigen-specific cytotoxic CD4+ICOShi T cells

乳腺癌患者接种乳球蛋白A cDNA疫苗可诱导抗原特异性细胞毒性CD4+ICOShi T细胞

Tiriveedhi, Venkataswarup; Fleming, Timothy P; Goedegebuure, Peter S; Naughton, Michael; Ma, Cynthia; Lockhart, Craig; Gao, Feng; Gillanders, William E; Mohanakumar, T

肿瘤

A genetically encoded multifunctional TRAIL trimer facilitates cell-specific targeting and tumor cell killing

基因编码的多功能TRAIL三聚体可促进细胞特异性靶向和肿瘤细胞杀伤

期刊:Molecular Cancer Therapeutics

影响因子:5.5

doi:10.1158/1535-7163.MCT-10-0225

Spitzer, Dirk; McDunn, Jonathan E; Plambeck-Suess, Stacey; Goedegebuure, Peter S; Hotchkiss, Richard S; Hawkins, William G

Sigma-2 receptor ligands potentiate conventional chemotherapies and improve survival in models of pancreatic adenocarcinoma

Sigma-2受体配体可增强传统化疗药物的疗效，并提高胰腺腺癌模型中的生存率。

期刊:Journal of Translational Medicine

影响因子:7.5

doi:10.1186/1479-5876-7-24

Kashiwagi, Hiroyuki; McDunn, Jonathan E; Simon, Peter O Jr; Goedegebuure, Peter S; Vangveravong, Suwanna; Chang, Katherine; Hotchkiss, Richard S; Mach, Robert H; Hawkins, William G

Targeting AKT with the proapoptotic peptide, TAT-CTMP: a novel strategy for the treatment of human pancreatic adenocarcinoma

利用促凋亡肽TAT-CTMP靶向AKT：治疗人胰腺腺癌的新策略

期刊:International Journal of Cancer

影响因子:4.7

doi:10.1002/ijc.24424

Simon, Peter O Jr; McDunn, Jonathan E; Kashiwagi, Hiroyuki; Chang, Katherine; Goedegebuure, Peter S; Hotchkiss, Richard S; Hawkins, William G

Tumor-derived TGF-beta mediates conversion of CD4+Foxp3+ regulatory T cells in a murine model of pancreas cancer.

在小鼠胰腺癌模型中，肿瘤来源的 TGF-β 介导 CD4+Foxp3+ 调节性 T 细胞的转化

期刊:Journal of Immunotherapy

影响因子:2.9

doi:10.1097/CJI.0b013e318189f13c

Moo-Young Tricia A, Larson Justin W, Belt Brian A, Tan Marcus C, Hawkins William G, Eberlein Timothy J, Goedegebuure Peter S, Linehan David C

Selective sigma-2 ligands preferentially bind to pancreatic adenocarcinomas: applications in diagnostic imaging and therapy

选择性σ-2配体优先结合胰腺腺癌：在诊断成像和治疗中的应用

期刊:Molecular Cancer

影响因子:33.9

doi:10.1186/1476-4598-6-48

Kashiwagi, Hiroyuki; McDunn, Jonathan E; Simon, Peter O Jr; Goedegebuure, Peter S; Xu, Jinbin; Jones, Lynne; Chang, Katherine; Johnston, Fabian; Trinkaus, Kathryn; Hotchkiss, Richard S; Mach, Robert H; Hawkins, William G

Understanding and addressing barriers to successful adenovirus-based virotherapy for ovarian cancer

了解并解决基于腺病毒的卵巢癌病毒疗法成功实施的障碍

Mammaglobin-A cDNA vaccination of breast cancer patients induces antigen-specific cytotoxic CD4+ICOShi T cells

乳腺癌患者接种乳球蛋白A cDNA疫苗可诱导抗原特异性细胞毒性CD4+ICOShi T细胞

A genetically encoded multifunctional TRAIL trimer facilitates cell-specific targeting and tumor cell killing

基因编码的多功能TRAIL三聚体可促进细胞特异性靶向和肿瘤细胞杀伤

Sigma-2 receptor ligands potentiate conventional chemotherapies and improve survival in models of pancreatic adenocarcinoma

Sigma-2受体配体可增强传统化疗药物的疗效，并提高胰腺腺癌模型中的生存率。

Targeting AKT with the proapoptotic peptide, TAT-CTMP: a novel strategy for the treatment of human pancreatic adenocarcinoma

利用促凋亡肽TAT-CTMP靶向AKT：治疗人胰腺腺癌的新策略

Tumor-derived TGF-beta mediates conversion of CD4+Foxp3+ regulatory T cells in a murine model of pancreas cancer.

在小鼠胰腺癌模型中，肿瘤来源的 TGF-β 介导 CD4+Foxp3+ 调节性 T 细胞的转化

Selective sigma-2 ligands preferentially bind to pancreatic adenocarcinomas: applications in diagnostic imaging and therapy

选择性σ-2配体优先结合胰腺腺癌：在诊断成像和治疗中的应用